Complete profile


Third-Party Information Liability Disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.




Last Updated: 2012-05-30

Jellett Biotek Consulting

Company information

 
 
Legal Name:   Dr. Joanne F.Jellett
Operating Name:   Jellett Biotek Consulting
 
Mailing Address
P.O. Box 344
CHESTER, Nova Scotia
B0J 1J0
 
Telephone: (902) 275-5760
Fax: (902) 275-5760
Email: jjellett@ns.sympatico.ca
 
Top

Contact information

 
Joanne Jellett
  Title:   President
  Telephone:   (902) 275-5760
  Fax:   (902) 275-5760
  Email:   jjellett@ns.sympatico.ca
 

Top

Company description

 
Consulting: development of biotoxin antibodies and rapid diagnostic tests, test development for WMDs
 
Country of Ownership: Canada  
Year Established: 2007
Exporting: Yes  
Primary Industry (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Services  
Total Sales ($CDN): $1,000,000 to $4,999,999 
Export Sales ($CDN): $1,000,000 to $4,999,999 
Number of Employees:

Top

Product / Service / Licensing

 
Service Name: Antibody development for biotoxins
 
consulting in biotoxin antibody development for all types of algal biotoxins

 
Service Name: Anti-terrorism antibody development
 
Consulting for development of antibioterrorism antibodies, and antibodies for potential agents of chemical terrorism

 
Service Name: Biosensor development
 
Consulting for development of biosensors for biotoxins and for potential agents of biological and chemical terrorism

 
Service Name: Rapid diagnostic test development
 
Consulting for development of rapid diagnostic tests for biotoxins, and for potential agents of chemical and biological terrorism

 

Top

Technology profile

Expertise in the development of antibodies for testing for agents of chemical and biological terrorism. Development of rapid diagnostic devices for WMD. Expertise in marine biotoxins.
Top

Market profile

Alliances:

  • Financial
  • Sales/Marketing
  • Technology

Industry sector market interests:

  • Environment
  • Fishery
  • Medical/Biotechnology/Chemical
  • Defence

Geographic markets:

Export experience:
  • Argentina
  • Australia
  • Belgium
  • Bermuda
  • Chile
  • China
  • Denmark
  • France
  • Germany
  • Hong Kong
  • Ireland
  • Israel
  • Italy
  • Japan
  • Korea, Republic of
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Philippines
  • Portugal
  • Singapore
  • Spain
  • Sweden
  • United Kingdom
  • United States
Actively pursuing:
  • Gibraltar
  • Greece
  • Greenland
  • Iceland
  • India
  • Peru

Top

Sector information

Unique applications:

The antibodies and test kits that I developed were capable of sensitively detecting all the members of the saxitoxin family up until the time of my departure from Jellett Rapid Testing Ltd in December 2005.

Key / Major clients:

Those who know the name of Dr. Joanne F. Jellett will know that it is synonymous with innovation, quality and dependability. Dr. Jellett has colleagues in Canada and in countries all over the world who can attest to her expertise - please enquire for a list of scientific and industry references that can describe how they have used the services of Dr. Jellett. Others may try to make claim to Dr. Jellett's expertise - but cannot achieve the same level of quality - there is only one Dr. Joanne F. Jellett.

Success stories:

I am the original developer of the rapid diagnostic tests for PSP, ASP and DSP that are now sold by my company Jellett Rapid Testing Ltd. I achieved what many others had attempted over a 12 year period that began in 1988 at the Department of Fisheries and Oceans, and continued between 1993-2001 in my company Jellett Biotek Ltd, where all three tests were originally developed. I continued this work in my second Company Jellett Rapid Testing Ltd. until my departure in December 2005. I also developed the quality management system for these test kits using a cGMP method, and was solely responsible for the quality of the test kits until my departure from Jellett Rapid Testing. Of course I did not make these extraordinary breakthroughs alone, but worked with an incredible team of biotoxin experts from the National Research Council of Canada, led by Dr. Michael Quilliam, and these developments would not have been possible without this great team. Others may try to claim my expertise, and the achievements of our team, but the world knows who made these developments, and no one has been able to reproduce them or achieve the quality that we attained.

Testimonial:

"…for those who are not familiar with Joanne’s work, she is the original developer of the “Jellett Rapid Test” kit for PSP and other biotoxins.... [which was] accepted through [the stringent technical and quality process of] the Interstate Shellfish Sanitation Conference (ISSC).
... As a state manager, I would be willing to sign on as a collaborator to any project that Joanne was a part of…[and] would find her an invaluable consultant, since she is one of only a handful of researchers who has [products of sufficient quality which] successfully made it through the [US Interstate Shellfish Sanitation Committee validation] process." Jan.22/08
Darcie Couture
Director, Biotoxin Monitoring for the State of Maine
darcie.couture@maine.gov
www.maine.gov/dmr/index.htm

Please enquire for a additional references.

International capital projects:

Dr. Jellett has provided her expertise to the aquaculture industry and regulatory government departments in Canada, the UK, many states in the US including Maine, Alaska, Washington and other States that experience large annual outbreaks of PSP, Mexico, France, Denmark, Spain, Portugal, Greece, Morocco, NZ, AU, Singapore, Philippines, and many other countries. References available on request.
Top



Note: This document is presented in the language provided by the author/source. Most of the information contained in Canadian Company Capabilities (CCC) has been provided by sources external to Industry Canada. The accuracy, currency and reliability of the information contained in CCC are the sole responsibility of the registered companies and related organizations. Industry Canada assumes no responsibility in this respect. The registered businesses shall ensure the continued monitoring of the information contained in CCC and ask that it be modified when necessary.